One-Year Evaluation of Paliperidone Palmitate 6-Monthly: Satisfaction and Perceived Effectiveness Among Patients, Relatives, and Clinicians

Patients, their carers and relatives as well as mental health professionals reported a high satisfaction rate with PP6M, and equally good or even better perceived effectiveness compared to PP1M, PP3M or other oral or LAIs antipsychotics in the majority of cases. Improved patient experience with PP6M could improve treatment continuity and reduce hospitalization rates.

Authors

Institutions

Publication Details

Journal
Patient Preference and Adherence
Published
2025-05-01
DOI
https://doi.org/10.2147/ppa.s517038
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

One-Year Evaluation of Paliperidone Palmitate 6-Monthly: Satisfaction and Perceived Effectiveness Among Patients, Relatives, and Clinicians

Ana Arance, Sofia Pappa, Aquilino Polaino Lorente, Rocío Sáez Povedano et al.
Patient Preference and Adherence
Schizophrenia research and treatment
article

One-Year Evaluation of Paliperidone Palmitate 6-Monthly: Satisfaction and Perceived Effectiveness Among Patients, Relatives, and Clinicians

Ana Arance, Sofia Pappa, Aquilino Polaino Lorente, Rocío Sáez Povedano, Guillermo Isidro García, Laura Mata Iturralde, Javier Vázquez-Bourgón, Santiago Ovejero, Sergio Sánchez Alonso, María Pilar Campos-Navarro, Juan Antonio García-Carmona, Enrique Baca‐García, Miguel Barberán Navalón, Paula Suárez‐Pinilla, Sergio Benavente-López, Claudia Ovejas-Catalán, Paloma Fuentes-Pérez, Alberto Raya Platero, Luis Alberto Forcen-Muñoz, Ana Luisa González-Galdámez, Mariluz Ramirez Bonilla, B. Fernández Abascal Puente, Miguel Omaña Colmenares, A. García-Pérez, Sofía Manchado Perero
article en

Abstract

Patients, their carers and relatives as well as mental health professionals reported a high satisfaction rate with PP6M, and equally good or even better perceived effectiveness compared to PP1M, PP3M or other oral or LAIs antipsychotics in the majority of cases. Improved patient experience with PP6M could improve treatment continuity and reduce hospitalization rates.

Patient Preference and AdherenceVol. Volume 19
Universidad de Cantabria (ES), Instituto de Salud Carlos III (ES), Centro de Investigación Biomédica en Red de Salud Mental (ES), Marqués de Valdecilla University Hospital (ES), Instituto de Investigación Marqués de Valdecilla (ES), Instituto de Investigación Biosanitaria de Granada (ES), Centro Tecnológico Nacional de la Conserva y Alimentación (ES), Hospital Universitario Fundación Jiménez Díaz (ES), Hospital General Universitario Los Arcos del Mar Menor (ES), Santa Lucía University General Hospital (ES), Hospital Universitario Lluís Alcanyís (ES), West London Mental Health NHS Trust (GB), Hospital Universitario Infanta Leonor (ES), Imperial College London (GB), Universidad Católica de Murcia (ES), Universidad de Murcia (ES)
Zero hunger
Openalex Percentile: Top 85%
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.